Autopsy report · NCT01564121
Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa
Cause of deathNo reason given
Life of this trial
- Registered 5 years 5 months after it had already started.
- Ran for about 5 years before it stopped.
- 24 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Nantes University Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Giant Cell Tumors of Bone
- Interventions
- acid Zoledronic
- Participants
- 24
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.